These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667 [TBL] [Abstract][Full Text] [Related]
8. First line chemotherapy in low risk gestational trophoblastic neoplasia. Alazzam M; Tidy J; Hancock BW; Osborne R Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319 [TBL] [Abstract][Full Text] [Related]
9. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119 [TBL] [Abstract][Full Text] [Related]
11. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia]. Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279 [No Abstract] [Full Text] [Related]
12. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675 [TBL] [Abstract][Full Text] [Related]